Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current and novel therapeutic strategies for the management of cystic fibrosis.

Expert opinion on drug delivery - 1 May 2021

Gbian Douweh Leyla, Omri Abdelwahab

Abstract excerpt

Introduction: Cystic fibrosis (CF), is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and affects thousands of people throughout the world. Lung disease is the leading cause of death in CF patients. Despite the advances in treatments, the management of CF mainly targets symptoms. Recent CFTR modulators however target common mutations in patients, alleviating symptoms of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Inflammation

Share to Mutation

Source

Identifiers

PMID: 33426936
DOI: 10.1080/17425247.2021.1874343

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current and novel therapeutic strategies for the management of cystic fibrosis.PMID 33426936Read ↗

Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic StrategiesSemantic proximity Read ↗

Emerging drugs for cystic fibrosisSemantic proximity Read ↗

Advances in the Cystic Fibrosis Drug Development PipelineSemantic proximity Read ↗

Non-viral mRNA cystic fibrosis therapies and their ongoing clinical trials.Semantic proximity Read ↗

Progress towards next-generation therapeutics for cystic fibrosis.Semantic proximity Read ↗

Emerging medicines to improve the basic defect in cystic fibrosis.Semantic proximity Read ↗

CFTR Modulators: Shedding Light on Precision Medicine for Cystic FibrosisSemantic proximity Read ↗

An update on new and emerging therapies for cystic fibrosis.Semantic proximity Read ↗

Genetic therapies in cystic fibrosis.Semantic proximity Read ↗

Advances in Cell and Gene-based Therapies for Cystic Fibrosis Lung DiseaseSemantic proximity Read ↗

New and emerging targeted therapies for cystic fibrosis.Semantic proximity Read ↗

A new era for people with cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.